Inventor · disambiguated record
Gunnar F. Kaufmann
Also filed as: KAUFMANN GUNNAR · KAUFMANN GUNNAR F
22 granted patents·17 pending applications·224 citations·filing 2008–2022
93Inventor score
Files withSORRENTO THERAPEUTICS INC33JANDA KIM D2KAUFMANN GUNNAR F1LEE TIEN-LI1ONCTERNAL THERAPEUTICS INC1
Top patents by PatentIndex Score
39 records- 0197US10058609B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Aug 28, 2018·17 cites·14 claims
- 0296US9175082B2Antigen binding proteins that bind PD-L1ZHOU HEYUE·Filed 2013·Granted Nov 3, 2015·178 cites·5 claims
- 0392US9676853B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2014·Granted Jun 13, 2017·15 cites·20 claims
- 0487US10301395B2Chemically-locked bispecific antibodiesSORRENTO THERAPEUTICS INC·Filed 2016·Granted May 28, 2019·3 cites·14 claims
- 0577US11878058B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2021·Granted Jan 23, 2024·0 cites·19 claims
- 0677US10584168B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2017·Granted Mar 10, 2020·1 cites·7 claims
- 0777US8859740B2Anti-infective binding proteins that bind AIP2KAUFMANN GUNNAR F·Filed 2013·Granted Oct 14, 2014·4 cites·5 claims
- 0874US10472413B2Anti-infective binding proteins that bind AIP2SORRENTO THERAPEUTICS INC·Filed 2017·Granted Nov 12, 2019·1 cites·9 claims
- 0974US2022242954A1Antigen Binding Proteins that Bind PD-1SORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1072US9631009B2Anti-infective binding proteins that bind AIP2SORRENTO THERAPEUTICS INC·Filed 2014·Granted Apr 25, 2017·1 cites·18 claims
- 1171US10272154B2Antigen binding proteins that bind WISP1SORRENTO THERAPEUTICS INC·Filed 2015·Granted Apr 30, 2019·1 cites·29 claims
- 1271US2022144971A1Chemically-Locked Bispecific AntibodiesSORRENTO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1369US11242391B2Antigen binding proteins that bind PD-1SORRENTO THERAPEUTICS INC·Filed 2020·Granted Feb 8, 2022·0 cites·7 claims
- 1469US11027012B2Antigen binding proteins that bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2018·Granted Jun 8, 2021·0 cites·10 claims
- 1569US9394371B2Antibody-mediated disruption of quorum sensing in bacteriaJANDA KIM D·Filed 2008·Granted Jul 19, 2016·2 cites·9 claims
- 1667US11267905B2Chemically-locked bispecific antibodiesSORRENTO THERAPEUTICS INC·Filed 2019·Granted Mar 8, 2022·0 cites·19 claims
- 1767US10799598B2Disulfide bridging conjugatesSORRENTO THERAPEUTICS INC·Filed 2018·Granted Oct 13, 2020·0 cites·18 claims
- 1866US10435479B2Chemically-locked bispecific antibodiesSORRENTO THERAPEUTICS INC·Filed 2015·Granted Oct 8, 2019·1 cites·9 claims
- 1965US11318202B2Antigen binding proteins that bind WISP1SORRENTO THERAPEUTICS INC·Filed 2019·Granted May 3, 2022·0 cites·28 claims
- 2063US10925968B2Cell internalizing compoundsSORRENTO THERAPEUTICS INC·Filed 2019·Granted Feb 23, 2021·0 cites·17 claims
- 2161US2021052738A1Disulfide Bridging ConjugatesSORRENTO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2260US2017182161A1Antigen Binding Proteins that Bind PD-L1SORRENTO THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2359US2023357793A1Oncolytic herpes simplex viruses (hsv) expressing immunomodulatory fusion proteinsSORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2459US2021138075A1Cell internalizing compoundsSORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2557US2024197881A1Dimeric Antigen Receptors (DARs) that Bind GD2SORRENTO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2656US10774135B2Variant antibodies that bind AIP2SORRENTO THERAPEUTICS INC·Filed 2018·Granted Sep 15, 2020·0 cites·13 claims
- 2755US2023061838A1Dimeric Antigen Receptors (DAR) That Bind CD20SORRENTO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2855US2023070988A1Combinations of egfr inhibitors and ror1 inhibitors for the treatment of cancerONCTERNAL THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2953US2022251168A1Dimeric Antigen Receptors (DAR) that Bind BCMASORRENTO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3053US2023183377A1Activatable antigen binding proteins with universal masking moietiesSORRENTO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3150US2022363758A1Heterodimeric Antibodies That Bind to CD38 and CD3SORRENTO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3248US12180294B2Dimeric antigen receptorsSORRENTO THERAPEUTICS INC·Filed 2020·Granted Dec 31, 2024·0 cites·10 claims
- 3347US2022324974A1Activatable Multi-Specific Antigen Binding Protein ComplexesSORRENTO THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3445US9879069B2Antibody therapeutics that bind OprFSORRENTO THERAPEUTICS INC·Filed 2015·Granted Jan 30, 2018·0 cites·25 claims
- 3544US10583193B2Cell penetrating peptide inhibitors of p53-MDM2 interactionSORRENTO THERAPEUTICS INC·Filed 2018·Granted Mar 10, 2020·0 cites·12 claims
- 3643US2018194859A1Linked Dual Antibodies Conjugated at a Hinge RegionSORRENTO THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3737US2017043020A1Antibody-mediated disruption of quorum sensing in bacteriaJANDA KIM D·Filed 2016·Application pending·0 cites
- 3837US2013224203A1Pharmaceutical Composition of Recombinant Polyclonal ImmunoglobulinsLEE TIEN-LI·Filed 2012·Application pending·0 cites
- 3936US2016326266A1Chemically-Locked Bispecific AntibodiesSORRENTO THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gunnar F. Kaufmann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →